Elucid, a precision medicine software platform for cardiovascular disease, raised $8 million in Series A financing. The funding round was led by MedTex Ventures and
Elucid, a precision medicine software platform for cardiovascular disease, raised $8 million in Series A financing. The funding round was led by MedTex Ventures and